Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market
Everest Medicines (HKEX 1952.HK) announced that it has entered into a commercialization license agreement with … Source: en.antaranews.com ЧитатьCruise tourism set to grow with new ship terminal